Mammary tumour development is dose-dependently inhibited by n-3 polyunsaturated fatty acids in the MMTV-neu(ndl)-YD5 transgenic mouse model

Lipids in Health and Disease

David WL Ma²  William J Muller¹  Kate Perez²  Salma A Abdelmagid²  Michael A Leslie² 

[1] Molecular Oncology Labs, McGill University, Royal Victoria Hospital, Montreal, QC, Canada;Department of Human Health and Nutritional Sciences, University of Guelph, Animal Science/Nutrition Building, Room 342, 491 Gordon Street, N1G 2W1 Guelph, ON, Canada

关键词: Phospholipids;    Tumour volume;    Tumour multiplicity;    Tumour;    Breast cancer;    MMTV-neu mice;    Mammary gland;    Docosahexaenoic acid;    Eicosapentaenoic acid;    n-3 PUFA;   

Others  :  801054
DOI  :  10.1186/1476-511X-13-96

 received in 2014-05-01, accepted in 2014-05-28,  发布年份 2014

【 摘 要 】

Background

Breast cancer is attributable to modifiable risk factors including the intake of dietary n-3 polyunsaturated fatty acids (PUFA). A key piece of evidence, yet to be addressed, that would demonstrate a causal relationship between n-3 PUFA and breast cancer, is a dose-dependent effect of n-3 PUFA on tumour outcomes. Thus, the objective of the present study was to determine whether n-3 PUFA reduces mammary gland tumor outcomes in a dose-dependent manner in female MMTV-neu(ndl)-YD5 transgenic mice, an aggressive model of human breast cancer.

Methods

Harems were provided one of three experimental diets comprised of 0, 3 or 9% (w/w) menhaden fish oil containing n-3 PUFA. Female offspring were weaned onto the same parental diet and maintained on their respective diet for 20 weeks. Tumour onset, size and multiplicity were measured throughout the study. Fatty acid composition of mammary gland and tumours were determined by gas–liquid chromatography.

Results

Tumour size was significantly (p < 0.05) reduced in a dose-dependent manner. n-3 PUFA were also incorporated in a dose-dependent manner; differential incorporation was observed for eicosapentaenoic and docosapentaenoic acids into mammary gland tissue, while docosahexaenoic acid was preferentially incorporated into tumours.

Conclusion

Overall, the present study provides fundamental knowledge about the dose-dependent effect of n-3 PUFA on tumour outcomes in a pre-clinical model and also sheds light on the differential role of individual n-3 PUFA on tumour outcomes.

【 授权许可】

   
2014 Leslie et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】

• [1]Kachuri L, De P, Ellison LF, Semenciw R: Cancer incidence, mortality and survival trends in Canada, 1970–2007. Chronic Dis Inj Can 2013, 33:69-80.
• [2]Iwasaki M, Tsugane S: Risk factors for breast cancer: epidemiological evidence from Japanese studies. Cancer Sci 2011, 102:1607-1614.
• [3]Saadatian-Elahi M, Norat T, Goudable J, Riboli E: Biomarkers of dietary fatty acid intake and the risk of breast cancer: a meta-analysis. Int J Cancer 2004, 111:584-591.
• [4]Berquin IM, Edwards IJ, Chen YQ: Multi-targeted therapy of cancer by omega-3 fatty acids. Cancer Lett 2008, 269:363-377.
• [5]Patterson RE, Flatt SW, Newman VA, Natarajan L, Rock CL, Thomson CA, Caan BJ, Parker BA, Pierce JP: Marine fatty acid intake is associated with breast cancer prognosis. J Nutr 2011, 141:201-206.
• [6]Maillard V, Bougnoux P, Ferrari P, Jourdan ML, Pinault M, Lavillonniere F, Body G, Le FO, Chajes V: N-3 and N-6 fatty acids in breast adipose tissue and relative risk of breast cancer in a case–control study in Tours, France. Int J Cancer 2002, 98:78-83.
• [7]Pala V, Krogh V, Muti P, Chajes V, Riboli E, Micheli A, Saadatian M, Sieri S, Berrino F: Erythrocyte membrane fatty acids and subsequent breast cancer: a prospective Italian study. J Natl Cancer Inst 2001, 93:1088-1095.
• [8]Shannon J, King IB, Moshofsky R, Lampe JW, Gao DL, Ray RM, Thomas DB: Erythrocyte fatty acids and breast cancer risk: a case–control study in Shanghai, China. Am J Clin Nutr 2007, 85:1090-1097.
• [9]Iyengar NM, Hudis CA, Gucalp A: Omega-3 fatty acids for the prevention of breast cancer: an update and state of the science. Curr Breast Cancer Rep 2013, 5:247-254.
• [10]Zheng JS, Hu XJ, Zhao YM, Yang J, Li D: Intake of fish and marine n-3 polyunsaturated fatty acids and risk of breast cancer: meta-analysis of data from 21 independent prospective cohort studies. BMJ 2013, 346:f3706.
• [11]Hilakivi-Clarke L, Clarke R, Onojafe I, Raygada M, Cho E, Lippman M: A maternal diet high in n - 6 polyunsaturated fats alters mammary gland development, puberty onset, and breast cancer risk among female rat offspring. Proc Natl Acad Sci U S A 1997, 94:9372-9377.
• [12]Yee LD, Agarwal D, Rosol TJ, Lehman A, Tian M, Hatton J, Heestand J, Belury MA, Clinton SK: The inhibition of early stages of HER-2/neu-mediated mammary carcinogenesis by dietary n-3 PUFAs. Mol Nutr Food Res 2013, 57:320-327.
• [13]Ravacci GR, Brentani MM, Tortelli T Jr, Torrinhas RS, Saldanha T, Torres EA, Waitzberg DL: Lipid raft disruption by docosahexaenoic acid induces apoptosis in transformed human mammary luminal epithelial cells harboring HER-2 overexpression. J Nutr Biochem 2013, 24:505-515.
• [14]MacLennan MB, Clarke SE, Perez K, Wood GA, Muller WJ, Kang JX, Ma DW: Mammary tumor development is directly inhibited by lifelong n-3 polyunsaturated fatty acids. J Nutr Biochem 2013, 24:388-395.
• [15]Yee LD, Young DC, Rosol TJ, VanBuskirk AM, Clinton SK: Dietary (n-3) polyunsaturated fatty acids inhibit HER-2/neu-induced breast cancer in mice independently of the PPARgamma ligand rosiglitazone. J Nutr 2005, 135:983-988.
• [16]Vail DM, MacEwen EG: Spontaneously occurring tumors of companion animals as models for human cancer. Cancer Invest 2000, 18:781-792.
• [17]Morse MA, Hobeika A, Osada T, Niedzwiecki D, Marcom PK, Blackwell KL, Anders C, Devi GR, Lyerly HK, Clay TM: Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2. J Transl Med 2007, 5:42. BioMed Central Full Text
• [18]Kang KS, Wang P, Yamabe N, Fukui M, Jay T, Zhu BT: Docosahexaenoic acid induces apoptosis in MCF-7 cells in vitro and in vivo via reactive oxygen species formation and caspase 8 activation. PLoS One 2010, 5:e10296.
• [19]Corsetto PA, Montorfano G, Zava S, Jovenitti IE, Cremona A, Berra B, Rizzo AM: Effects of n-3 PUFAs on breast cancer cells through their incorporation in plasma membrane. Lipids Health Dis 2011, 10:73. BioMed Central Full Text
• [20]Ma DW, Seo J, Switzer KC, Fan YY, McMurray DN, Lupton JR, Chapkin RS: n-3 PUFA and membrane microdomains: a new frontier in bioactive lipid research. J Nutr Biochem 2004, 15:700-706.
• [21]Ma DW: Lipid mediators in membrane rafts are important determinants of human health and disease. Appl Physiol Nutr Metab 2007, 32:341-350.
• [22]Weisburger JH: Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J Am Diet Assoc 1997, 97:S16-S23.
• [23]Maclennan M, Ma DW: Role of dietary fatty acids in mammary gland development and breast cancer. Breast Cancer Res 2010, 12:211. BioMed Central Full Text
• [24]Kris-Etherton PM, Innis S, Ammerican DA, Dietitians of Canada: Position of the American Dietetic Association and Dietitians of Canada: dietary fatty acids. J Am Diet Assoc 2007, 107:1599-1611.
• [25]Yee LD, Lester JL, Cole RM, Richardson JR, Hsu JC, Li Y, Lehman A, Belury MA, Clinton SK: Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition. Am J Clin Nutr 2010, 91:1185-1194.
• [26]Turner N, Mitchell TW, Else PL, Hulbert AJ: The omega-3 and omega-6 fats in meals: a proposal for a simple new label. Nutrition 2011, 27:719-726.
• [27]Liu YE, Pu W, Wang J, Kang JX, Shi YE: Activation of Stat5 and induction of a pregnancy-like mammary gland differentiation by eicosapentaenoic and docosapentaenoic omega-3 fatty acids. FEBS J 2007, 274:3351-3362.
• [28]Kremmyda LS, Tvrzicka E, Stankova B, Zak A: Fatty acids as biocompounds: their role in human metabolism, health and disease: a review. part 2: fatty acid physiological roles and applications in human health and disease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2011, 155:195-218.
• [29]Park SK, Kim Y, Kang D, Jung EJ, Yoo KY: Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea. J Breast Cancer 2011, 14:79-87.
• [30]Biro FM, Greenspan LC, Galvez MP, Pinney SM, Teitelbaum S, Windham GC, Deardorff J, Herrick RL, Succop PA, Hiatt RA, Kushi LH, Wolff MS: Onset of breast development in a longitudinal cohort. Pediatrics 2013, 132:1019-1027.
• [31]Biro FM, Deardorff J: Identifying opportunities for cancer prevention during preadolescence and adolescence: puberty as a window of susceptibility. J Adolesc Health 2013, 52:S15-S20.
• [32]Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.